Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing a first-in-class pipeline of induced pluripotent stem cell therapeutics. The company is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders.
Focus Areas
Notable Investments
